Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Anti-RHAMM monoclonal antibodies useful for proliferative diseases

July 3, 2000

Small molecule from Novartis is a specific inhibitor of cdk4 kinase

July 3, 2000

Novel alkaloids isolated from Daphniphyllum exert cytotoxic effects against cancer cells

July 3, 2000

Kinase inhibitor PKC-412 exhibits both antiproliferative and antiangiogenic properties

July 3, 2000

Tumor growth and spread blocked by inhibition of RAGE-amphoterin interaction

July 3, 2000

FDA approves Targretin gel for treatment of cutaneous T-cell lymphoma

June 30, 2000

Sch-66336 warrants further evaluation for the treatment of glioblastoma multiforme

June 29, 2000

EB-1089 as a potential agent for the management of refractory thyroid carcinoma

June 29, 2000

PTK-787/ZK-222584 expected to show improved selectivity as kinase inhibitor, according to SAR

June 29, 2000

Development of CI-1033, an irreversible inhibitor of EGF tyrosine kinase activity

June 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...